Market Place
Inke S.A: APIs manufacturing plant. 
X
Please Wait
Applying Filters...
01 INKE, S.A. (1)
02 PCAS FINLAND OY (1)
03 Anonima Materie Sintetiche and Affini (AMSA) Spa (2)
04 AstraZeneca AB (2)
05 AstraZeneca Pharmaceuticals LP (2)
06 Cerbios-Pharma SA (1)
07 Fagron Inc (1)
08 HARMAN FINOCHEM LIMITED (1)
09 Hainan Poly Pharm. Co., Ltd. (1)
10 Harman Finochem Limited (1)
11 Hikma Pharmaceuticals (1)
12 LETCO MEDICAL, LLC (1)
13 Medisca Inc. (1)
14 Olon SpA (1)
15 Professional Compounding Centers of America dba PCCA (1)
16 Spectrum Laboratory Products, Inc. (1)
17 Suven Pharmaceuticals Limited (1)
18 Suven Pharmaceuticals Ltd (1)
01 GLYCOPYRROLATE (3)
02 GLYCOPYRROLATE TOSYLATE (1)
03 Glycopirronium Bromide (1)
04 Glycopyrrolate (10)
05 Glycopyrrolate Tosylate (1)
06 Glycopyrronium Tosylate Monohydrate (1)
07 Micronized Glycopyrronium Bromide (4)
01 China (1)
02 France (1)
03 India (4)
04 Italy (3)
05 Netherlands (1)
06 Spain (1)
07 Switzerland (1)
08 U.S.A (3)
09 United Kingdom (6)
15
PharmaCompass offers a list of Glycopyrronium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier.
PharmaCompass also assists you with knowing the Glycopyrronium Bromide API Price utilized in the formulation of products. Glycopyrronium Bromide API Price is not always fixed or binding as the Glycopyrronium Bromide Price is obtained through a variety of data sources. The Glycopyrronium Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3109 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3109, including repackagers and relabelers. The FDA regulates DSSTox_CID_3109 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3109 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3109 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3109 supplier is an individual or a company that provides DSSTox_CID_3109 active pharmaceutical ingredient (API) or DSSTox_CID_3109 finished formulations upon request. The DSSTox_CID_3109 suppliers may include DSSTox_CID_3109 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3109 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_3109 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_3109 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DSSTox_CID_3109 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_3109 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_3109 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DSSTox_CID_3109 suppliers with NDC on PharmaCompass.
We have 15 companies offering DSSTox_CID_3109
Get in contact with the supplier of your choice:
